BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 33492286)

  • 21. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting the time to clinically worsening in mild cognitive impairment patients and its utility in clinical trial design by modeling a longitudinal clinical dementia rating sum of boxes from the ADNI database.
    Ito K; Hutmacher MM
    J Alzheimers Dis; 2014; 40(4):967-79. PubMed ID: 24531162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction?
    Abner EL; Kryscio RJ; Schmitt FA; Santacruz KS; Jicha GA; Lin Y; Neltner JM; Smith CD; Van Eldik LJ; Nelson PT
    J Alzheimers Dis; 2011; 25(3):445-53. PubMed ID: 21471646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial.
    Ornish D; Madison C; Kivipelto M; Kemp C; McCulloch CE; Galasko D; Artz J; Rentz D; Lin J; Norman K; Ornish A; Tranter S; DeLamarter N; Wingers N; Richling C; Kaddurah-Daouk R; Knight R; McDonald D; Patel L; Verdin E; E Tanzi R; Arnold SE
    Alzheimers Res Ther; 2024 Jun; 16(1):122. PubMed ID: 38849944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study.
    O'Bryant SE; Waring SC; Cullum CM; Hall J; Lacritz L; Massman PJ; Lupo PJ; Reisch JS; Doody R;
    Arch Neurol; 2008 Aug; 65(8):1091-5. PubMed ID: 18695059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages.
    Brugnolo A; Orso B; Girtler N; Ferraro PM; Arnaldi D; Mattioli P; Massa F; Famà F; Argenti L; Biffa G; Morganti W; Buonopane S; Uccelli A; Morbelli S; Pardini M
    Cortex; 2024 Feb; 171():413-422. PubMed ID: 38113612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting functional decline in aging and Alzheimer's disease with PET-based Braak staging.
    Macedo AC; Therriault J; Tissot C; Fernandez-Arias J; Ferreira PCL; Vitali P; Servaes S; Rahmouni N; Vermeiren M; Bezgin G; Lussier FZ; Stevenson J; Wang YT; Socualaya KQ; Kunach P; Nazneen T; Hosseini SA; Pallen V; Stevenson A; Ferrari-Souza JP; Bellaver B; Leffa DT; Ng KP; Zimmer ER; Pascoal TA; Gauthier S; Rosa-Neto P
    Brain Commun; 2024; 6(2):fcae043. PubMed ID: 38482373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linking the Clinical Dementia Rating Scale-Sum of Boxes, the Clinician's Interview-Based Impression Plus Caregiver Input, and the Clinical Global Impression Scale: Evidence based on Individual Participant Data from Five Randomized Clinical Trials of Donepezil.
    Samara M; Levine SZ; Yoshida K; Goldberg Y; Cipriani A; Efthimiou O; Iwatsubo T; Leucht S; Furakawa TA
    J Alzheimers Dis; 2021; 82(3):1075-1084. PubMed ID: 34120898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical validity of Braak neuropathological staging in the oldest-old.
    Gold G; Bouras C; Kövari E; Canuto A; Glaría BG; Malky A; Hof PR; Michel JP; Giannakopoulos P
    Acta Neuropathol; 2000 May; 99(5):579-82; discussion 583-4. PubMed ID: 10805104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Memory and mental status correlates of modified Braak staging.
    Grober E; Dickson D; Sliwinski MJ; Buschke H; Katz M; Crystal H; Lipton RB
    Neurobiol Aging; 1999; 20(6):573-9. PubMed ID: 10674422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Informant characteristics are associated with the Clinical Dementia Rating Sum of Boxes scores in the Alzheimer's Disease patients participating in the National Alzheimer's Coordinating Center Uniform Data Set.
    Vargas-Gonzalez JC; Chadha AS; Castro-Aldrete L; Ferretti MT; Tartaglia C
    Res Sq; 2024 Mar; ():. PubMed ID: 38559129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics.
    Eldholm RS; Barca ML; Persson K; Knapskog AB; Kersten H; Engedal K; Selbæk G; Brækhus A; Skovlund E; Saltvedt I
    J Alzheimers Dis; 2018; 61(3):1221-1232. PubMed ID: 29254085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional assessment staging (FAST) in Korean patients with Alzheimer's disease.
    Na HR; Kim SY; Chang YH; Park MH; Cho ST; Han IW; Kim TY; Hwang SA
    J Alzheimers Dis; 2010; 22(1):151-8. PubMed ID: 20847407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum.
    Serrano-Pozo A; Qian J; Muzikansky A; Monsell SE; Montine TJ; Frosch MP; Betensky RA; Hyman BT
    J Neuropathol Exp Neurol; 2016 Jun; 75(6):516-26. PubMed ID: 27105663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropathologic validation of the Alzheimer's Questionnaire.
    Mohebpour I; Malek-Ahmadi M; Virden T; Breitmeyer A; Sabbagh MN; Auman B; Belden CM; Choudhury P; Arch A; Davis K; Cline C; Moorley N; Atri A; Serrano G; Beach TG
    Aging Clin Exp Res; 2022 Nov; 34(11):2905-2909. PubMed ID: 36031683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
    Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
    Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive composite score association with Alzheimer's disease plaque and tangle pathology.
    Malek-Ahmadi M; Chen K; Perez SE; He A; Mufson EJ
    Alzheimers Res Ther; 2018 Sep; 10(1):90. PubMed ID: 30205840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy.
    Teylan M; Mock C; Gauthreaux K; Chen YC; Chan KCG; Hassenstab J; Besser LM; Kukull WA; Crary JF
    Brain; 2020 Feb; 143(2):611-621. PubMed ID: 31942622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer disease pathology and longitudinal cognitive performance in the oldest-old with no dementia.
    Balasubramanian AB; Kawas CH; Peltz CB; Brookmeyer R; Corrada MM
    Neurology; 2012 Aug; 79(9):915-21. PubMed ID: 22895581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progression of Alzheimer's disease as measured by Clinical Dementia Rating Sum of Boxes scores.
    Williams MM; Storandt M; Roe CM; Morris JC
    Alzheimers Dement; 2013 Feb; 9(1 Suppl):S39-44. PubMed ID: 22858530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.